Recent investment activity

KANDO id: 37834

Corporate information

Registration country

Funding rounds

Profile Country
BioEnterprise


Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Country Date Funding
Incuron Developer of the innovative class of drug substance (curaxins) for oncological and autoimmune treatment diseases N/A

Current team

Past employees

Selected Products / Customers

Financials